OTCMKTS:BCYP Big Cypress Acquisition (BCYP) Stock Price, News & Analysis $8.44 -2.01 (-19.23%) (As of 10/22/2021) Add Compare Share Share Today's Range$8.21▼$12.9050-Day Range$8.44▼$8.4452-Week Range$8.21▼$12.90Volume15.34 million shsAverage Volume160,982 shsMarket Capitalization$124.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Big Cypress Acquisition alerts: Email Address Ad Stansberry ResearchGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."Click here now to watch this exclusive interview About Big Cypress Acquisition Stock (OTCMKTS:BCYP)Big Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.Read More BCYP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BCYP Stock News HeadlinesJuly 27 at 4:22 AM | americanbankingnews.comBig Cypress Acquisition (OTCMKTS:BCYP) Stock Crosses Below Two Hundred Day Moving Average of $8.44July 19, 2024 | americanbankingnews.comBig Cypress Acquisition (OTCMKTS:BCYP) Share Price Passes Below Two Hundred Day Moving Average of $8.44July 27, 2024 | Stansberry Research (Ad)Get out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."November 13, 2023 | foxnews.comFlorida men capture massive 17-foot, 200-pound invasive python in EvergladesOctober 15, 2023 | thestreet.comSolar Stock Losers in Sharp's Big U.S. AcquisitionSeptember 10, 2023 | usatoday.comBig 12 college football conference preview: Oklahoma, Texas ready to ride off into sunsetAugust 18, 2023 | finance.yahoo.comBig Ridge Gold Completes Acquisition of Gold Island Inc. Creating a Premier Newfoundland Based Exploration CompanyApril 4, 2023 | forbes.comBig Ass FansJuly 27, 2024 | Stansberry Research (Ad)Get out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."March 2, 2022 | reuters.comSAB Biotherapeutics IncOctober 21, 2021 | finance.yahoo.comBig Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB BiotherapeuticsOctober 4, 2021 | finance.yahoo.comSAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19September 28, 2021 | finance.yahoo.comSAB Biotherapeutics Appoints Russell Beyer Chief Financial OfficerSeptember 24, 2021 | finance.yahoo.comSAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19September 22, 2021 | finance.yahoo.comSAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19September 15, 2021 | finance.yahoo.comSAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal InfluenzaSeptember 8, 2021 | finance.yahoo.comSAB Biotherapeutics to Present at Upcoming September Virtual Investor ConferencesAugust 11, 2021 | barrons.comBig Cypress Acquisition Corp.See More Headlines Receive BCYP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2014Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryPersonal Services Current SymbolOTCMKTS:BCYP CUSIPN/A CIK1399587 Webwww.bluecalypso.com Phone305-204-3338FaxN/AEmployees17Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio6.13 Quick Ratio6.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares14,792,000Free FloatN/AMarket Cap$124.84 million OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Samuel J. Reich (Age 46)CEO, CFO & Director Key CompetitorsAllegoNYSE:ALLGYoudaoNYSE:DAOCheggNYSE:CHGGVasta PlatformNASDAQ:VSTAHong Kong Technology VentureOTCMKTS:HKTVYView All Competitors BCYP Stock Analysis - Frequently Asked Questions How have BCYP shares performed this year? Big Cypress Acquisition's stock was trading at $8.44 on January 1st, 2024. Since then, BCYP shares have increased by 0.0% and is now trading at $8.44. View the best growth stocks for 2024 here. How were Big Cypress Acquisition's earnings last quarter? Big Cypress Acquisition Corp. (OTCMKTS:BCYP) issued its earnings results on Tuesday, November, 11th. The technology company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to analysts' expectations of $0.21 million. How do I buy shares of Big Cypress Acquisition? Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Big Cypress Acquisition own? Based on aggregate information from My MarketBeat watchlists, some other companies that Big Cypress Acquisition investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP) and Ascent Solar Technologies (ASTI). This page (OTCMKTS:BCYP) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Big Cypress Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Big Cypress Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.